Millennium Conference on Nucleic Acid Therapeutics 8-11 January

Dr. Eric Wickstrom eric at tesla.jci.tju.edu
Wed Nov 10 18:13:05 EST 1999


Millennium Conference on Nucleic Acid Therapeutics - see
http://tesla.jci.tju.edu/millennium.html

               8-11 January, 2000    Clearwater Beach, Florida 

Conference Focus:

      A broad international research effort to develop nucleic acid analogs
and vectors as
therapeutics for cancers, chronic diseases, and microorganisms has finally
led to clinical trials
and the first FDA approval of a DNA drug. Great progress has occurred since
the last
Clearwater Beach meeting in 1991. The 2000 meeting will provide a forum
whereby the most
recent developments in preparing gene specific drugs and vectors, and
applying those agents
in preclinical and clinical trials will be shared among scientists,
clinicians, and regulators from
around the world. The conference is supported by the International Union of
Biochemistry
and Molecular Biology, the US National Institutes of Health, and
biotechnology firms. 

Conference Design:

     Participants will arrive at the Hilton Clearwater Beach Resort on a
Saturday, then attend
plenary sessions in the morning and evening on Sunday, Monday, and Tuesday,
with departure
on Wednesday morning. Poster sessions will be held in the afternoons,
leaving participants
free to discuss mutual research interests and develop new projects. The
great majority of
participants are expected to stay at the hotel, and eat all their meals
together. The cost of food
is included in the $500 registration fee. This meeting design encourages
the maximum possible
interaction of participants. Participation will be limited to 300 persons.
Please email additional questions to the organizer, eric at tesla.jci.tju.edu. 

Conference Sessions:

                   Sunday Morning:    Oligonucleotide Derivatives
Dr. Maria Koziolkiewicz, Lodz Centre of Molecular & Macromolecular Studies
Dr. Akira Murakami, Kyoto Institute of Technology
Dr. Peter Nielsen, University of Copenhagen
Dr. Barbara Shaw, Duke University
Dr. James Summerton, GeneTools
Dr. Valentina Zarytova, Novosibirsk Institute of Bioorganic Chemistry

                 Sunday Evening:    Diagnostic Oligonucleotide Chips
Dr. Michael Boyce-Jacino, Orchid Biocomputer
Dr. Francois Chatelain, ProtoGene
Dr. Vladimir Efimov, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry
Dr. Glenn McGall, Affymetrix
Dr. Andrei Mirzabekov, Argonne National Laboratory
Dr. Edwin Southern, Oxford University

                 Monday Morning:    Mechanisms and Pharmacology
Dr. Sudhir Agrawal, Hybridon
Dr. Susan Freier, Isis Pharmaceuticals
Dr. Jean-Louis Imbach, Université de Montpellier
Dr. Rudolph L. Juliano, University of North Carolina
Dr. Ülo Langel, Stockholm University
Dr. Jean-Jacques Toulmé, Université Victor Segalen

                       Monday Evening:    Preclinical Trials
Dr. Esther Chang, Georgetown University
Dr. Patrick Iversen, AVI BioPharma
Dr. Daniela Verthelyi, Food and Drug Administration
Dr. Valentin Vlassov, Novosibirsk Institute of Bioorganic Chemistry
Dr. Claes Wahlestedt, Karolinska Institutet
Dr. Paul Zamecnik, Massachusetts General Hospital

                     Tuesday Morning:   Gene Therapy Vectors
Dr. Dennis Klinman, Food and Drug Administration
Dr. Eric Kmiec, University of Delaware
Dr. Daniel Mercola, Sidney Kimmel Cancer Center
Dr. Arun Srivastava, Indiana University School of Medicine
Dr. Richard Vile, Mayo Clinic
Dr. Eric Wickstrom, Thomas Jefferson University

                        Tuesday Evening:    Clinical Trials
Dr. Yoon Cho-Chung, National Cancer Institute
Dr. John Rossi, City of Hope
Dr. Branimir Sikic, Stanford University
Dr. Alison Stopeck, University of Arizona
Dr. Stephen Swisher, University of Texas
Dr. Nissim Usman, Ribozyme Pharmaceuticals

Conference Location:  Hilton Clearwater Beach Resort
                             400 Mandalay Avenue
                         Clearwater Beach, Florida 33767
                  800-753-3954 or 727-461-3222; fax=727-446-1583

Conference Travel: Nancy Volk, Naylor Travel Group
                 111 E. Lancaster Avenue, Devon, Pennsylvania 19333
                  800-355-7901 or 610-964-7900; fax=610-964-9101

Conference Supporters: Glen Research
                              Research Genetics
                                 Gene Tools
                                  Novartis
                            TriLink BioTechnologies
                          Amersham Pharmacia Biotech
              International Union of Biochemistry and Molecular Biology
                             Rhône-Poulenc Rorer
                                   Inex Pharmaceuticals
                         US National Institutes of Health
                                  Annovis
                                PE Biosystems
                              Berry & Associates
                          Integrated DNA Technologies
                                 Hybridon
Good luck with your work.

		Sincerely, Eric Wickstrom

Professor Eric Wickstrom
Department of Microbiology and Immunology
Thomas Jefferson University
1025 Walnut Street, Suite 420
Philadelphia PA 19107-5083

voice: 215-955-4578         fax: 215-955-4580, 215-923-9214, 815-352-0382

http://tesla.jci.tju.edu 

Millennium Conference on Nucleic Acid Therapeutics, 8-11 January 2000:
http://tesla.jci.tju.edu/millennium.html





More information about the Bionews mailing list